← Leaderboards
Fracisco A Bonilla
Children'S Hospital Boston
$34,275
Attributed
$290,760
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $279.8K · FY2005–14$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$290,760 · 5
By mechanism
R34$279,802 · 1
M01$10,958 · 4
Top collaborators
- Charlotte Cunningham-Rundles1 shared
- Raif Salim Geha1 shared
- Katherne E Gundling1 shared
- Michael E Kelly1 shared
- Laura L Koth1 shared
- Anna Kovalszki1 shared
- David J Rawlings1 shared
- John Michael Routes1 shared
Most similar at Children'S Hospital Boston
Same institution · by research overlap
- Raif Salim Geha$43,046,244
- Ellis J Neufeld$12,060,310
- Leonard I Zon$62,884,258
Others in their field
Top investigators on “Grant”
- David R. Weir · University Of Michigan At Ann Arbor$373,949,788
- David Heimbrook · Leidos Biomedical Research, Inc.$341,196,902
- Eric S Lander · Whitehead Institute For Biomedical Res$323,181,457
- Jeffrey P Krischer · University Of South Florida$258,583,867
- Lawrence Corey · Fred Hutchinson Cancer Center$253,286,867
- Barton F Haynes · Duke University$243,251,908
Research focus
GrantResearch PersonnelComputer Retrieval Of Information On Scientific Projects DatabaseUnited States National Institutes Of HealthFundingAntibodiesSourceResourcesInstitutionBaseCity Of BostonChestClinical TrialsClinical Trials Data Monitoring CommitteesAzathioprineAftercareCd20 AntigensComputer SoftwareCause Of DeathAnti-IgaCongenital ImmunodeficiencyConsensusCostComplication
Grant awards (5)
GLILD in CVID$279,802
R34 · FY2014 · AI
STUDIES ON ANTIBODY DEFICIENCY SYNDROME$1,447
M01 · FY2007 · RR · contact PI
ANTI-IGA ANTIBODIES WITH ADVERSE REACTIONS TO GAMMA GLOBULIN INFUSION$722
M01 · FY2007 · RR · contact PI
STUDIES ON ANTIBODY DEFICIENCY SYNDROME$4,431
M01 · FY2006 · RR · contact PI
STUDIES ON ANTIBODY DEFICIENCY SYNDROME$4,358
M01 · FY2005 · RR